Several studies demonstrated increased levels of IL-17 and GM-CSF in peripheral blood and tears of patients with COVID-19, and a higher fraction of Th17 cells in bronchoalveolar lavage fluid of these patients [11,62,63,64,65,66,67,68,69]. The gene discussed is CSF2; the disease is COVID-19.